10.1093/oxfordjournals.humrep.a019080 60
Inform your healthcare provider that you take Mounjaro, including your dosage, duration of treatment, and any gastrointestinal symptoms
What This Means for Women in Midlife If you're considering a GLP-1 medication for weight management, the question isn't just "which medication?" it's "what else is going on hormonally?" For women in perimenopause or postmenopause, addressing estrogen deficiency may: Enhance the weight loss response to GLP-1 medications [1] Improve the metabolic benefits including better insulin sensitivity and reduced visceral fat [7, 8] Address symptoms like sleep disruption, hot flashes, and mood changes that can undermine weight loss efforts [10] Support long-term cardiovascular health during a period of accelerated risk [9] This is why a comprehensive approach one that evaluates both your metabolic health and your hormonal status matters so much more than choosing a single medication in isolation

Nonetheless, a decrease in PI3K, Akt, mTOR, proliferation, migration, invasion, p-ERK1/2, growth, colony formation, and inflammation represented by nuclear factor B (NF-B) expression, cell viability, and an overall decrease in proliferation was noted with applying liraglutide (Table 1)
Normally, glutathione helps neutralize some of that stress